Print
Email

Email

BRIEF-Summit Therapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4)

Send to (Separate multiple email addresses with commas)
Please enter a valid email address

Your email address
Please enter a valid email address

Message (Optional)

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Email

Your email has been sent.
Share
Share
BRIEF-Summit Therapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4)

Clicking a link will open a new window.
Default text size A
Larger text size A
Largest text size A

BRIEF-Summit Therapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4)

, Reuters - 4:20 PM ET 3/21/2025 default

March 21 (Reuters) - Summit Therapeutics Inc ( SMMT ):

* SUMMIT THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: Further company coverage:

(c) Reuters 2025. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

BRIEF-Summit Therapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4)

Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.

Your e-mail has been sent.

BRIEF-Court Reduces Wabash National's Punitive Damages To $108 Mln- SEC filing

Reuters - 21 minutes ago
Electra Battery Materials Gets Non-Binding Deal for $20 Million to Fund Cobalt Refinery, to Raise US$3.5 Million in Private Placement

MT Newswires - 21 minutes ago
Truist Lowers Price Target on Plymouth Industrial REIT to $18 From $20, Keeps Hold Rating

MT Newswires - 23 minutes ago
Nomura Cuts Price Target on NIO to $5 From $7.50, Keeps Neutral Rating

MT Newswires - 25 minutes ago
Guggenheim Upgrades Pinterest to Buy From Neutral, Adjusts Price Target to $40 From $39

MT Newswires - 25 minutes ago
Egypt makes new proposal to restore Gaza ceasefire deal, sources say

Reuters - 25 minutes ago
Redburn Atlantic Upgrades Wyndham Hotels & Resorts to Buy From Neutral, Adjusts PT to $115 From $110

MT Newswires - 25 minutes ago
Redburn Atlantic Upgrades Choice Hotels International to Neutral From Sell, Adjusts PT to $132 From $128

MT Newswires - 27 minutes ago

Content for this page, unless otherwise indicated with a Fidelity pyramid logo, is selected and published by Fidelity Interactive Content Services LLC ("FICS"), a Fidelity company. All Web pages published by FICS will contain this legend. FICS was established to present users with objective news, information, data and guidance on personal finance topics drawn from a diverse collection of sources including affiliated and non-affiliated financial services publications. Content selected and published by FICS drawn from affiliated Fidelity companies is labeled as such. FICS-selected content provided is not intended to provide tax, legal, insurance, or investment advice, and should not be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by any Fidelity entity or any third party. Quotes are delayed unless otherwise noted. FICS is owned by FMR LLC and is an affiliate of Fidelity Brokerage Services LLC. Terms of use for Third-Party Content and Research

These links are provided by Fidelity Brokerage Services LLC ("FBS") for educational and informational purposes only. FBS is responsible for the information contained in the links. FICS and FBS are separate but affiliated companies and FICS is not involved in the preparation or selection of these links, nor does it explicitly or implicitly endorse or approve information contained in the links.

Before investing, consider the funds' investment objectives, risks, charges, and expenses. Contact Fidelity for a prospectus or, if available, a summary prospectus containing this information. Read it carefully.